Prof Steve Jackson

News

UK biotech company Mission Therapeutics has raised £60 million to invest into its drug discovery and development programme.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.